CN102898326B - 盐酸金霉素的制备方法 - Google Patents
盐酸金霉素的制备方法 Download PDFInfo
- Publication number
- CN102898326B CN102898326B CN201210426529.0A CN201210426529A CN102898326B CN 102898326 B CN102898326 B CN 102898326B CN 201210426529 A CN201210426529 A CN 201210426529A CN 102898326 B CN102898326 B CN 102898326B
- Authority
- CN
- China
- Prior art keywords
- add
- isphamycin
- coarse
- filtrate
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 title abstract 3
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 claims abstract description 37
- 229960004475 chlortetracycline Drugs 0.000 claims abstract description 37
- 235000019365 chlortetracycline Nutrition 0.000 claims abstract description 37
- 238000005406 washing Methods 0.000 claims abstract description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 35
- 150000003839 salts Chemical class 0.000 claims abstract description 28
- 238000000855 fermentation Methods 0.000 claims abstract description 21
- 230000004151 fermentation Effects 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000001914 filtration Methods 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- 238000002425 crystallisation Methods 0.000 claims abstract description 14
- 230000008025 crystallization Effects 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 5
- CBHYYLPALVVVEY-MRFRVZCGSA-N chembl2146063 Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CBHYYLPALVVVEY-MRFRVZCGSA-N 0.000 claims description 55
- 239000000706 filtrate Substances 0.000 claims description 48
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 20
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 19
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 16
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 claims description 16
- 239000006210 lotion Substances 0.000 claims description 16
- 238000013019 agitation Methods 0.000 claims description 13
- 238000001556 precipitation Methods 0.000 claims description 11
- 239000013078 crystal Substances 0.000 claims description 10
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 8
- 238000009413 insulation Methods 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 8
- 239000006166 lysate Substances 0.000 claims description 7
- 235000006408 oxalic acid Nutrition 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- GTSHREYGKSITGK-UHFFFAOYSA-N sodium ferrocyanide Chemical compound [Na+].[Na+].[Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] GTSHREYGKSITGK-UHFFFAOYSA-N 0.000 claims description 7
- 235000012247 sodium ferrocyanide Nutrition 0.000 claims description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 7
- 229960001763 zinc sulfate Drugs 0.000 claims description 7
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 7
- 238000000861 blow drying Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 239000002893 slag Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 241001454747 Streptomyces aureus Species 0.000 abstract description 3
- 229930101283 tetracycline Natural products 0.000 abstract description 3
- 238000007670 refining Methods 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract 3
- 230000020477 pH reduction Effects 0.000 abstract 2
- 238000004062 sedimentation Methods 0.000 abstract 2
- FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 abstract 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 abstract 1
- 229960002398 demeclocycline Drugs 0.000 abstract 1
- FMTDIUIBLCQGJB-SEYHBJAFSA-N demeclocycline Chemical compound C1([C@@H](O)[C@H]2C3)=C(Cl)C=CC(O)=C1C(=O)C2=C(O)[C@@]1(O)[C@@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FMTDIUIBLCQGJB-SEYHBJAFSA-N 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 abstract 1
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 description 31
- 244000144972 livestock Species 0.000 description 3
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- GUXHBMASAHGULD-SEYHBJAFSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=C(Cl)C=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O GUXHBMASAHGULD-SEYHBJAFSA-N 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000186984 Kitasatospora aureofaciens Species 0.000 description 1
- 206010028140 Mucous stools Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940072172 tetracycline antibiotic Drugs 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210426529.0A CN102898326B (zh) | 2012-10-31 | 2012-10-31 | 盐酸金霉素的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210426529.0A CN102898326B (zh) | 2012-10-31 | 2012-10-31 | 盐酸金霉素的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102898326A CN102898326A (zh) | 2013-01-30 |
CN102898326B true CN102898326B (zh) | 2014-03-19 |
Family
ID=47570850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210426529.0A Active CN102898326B (zh) | 2012-10-31 | 2012-10-31 | 盐酸金霉素的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102898326B (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103614446A (zh) * | 2013-03-29 | 2014-03-05 | 驻马店华中正大有限公司 | 一种添加金属离子提高金霉素产量的发酵工艺 |
CN103739514B (zh) * | 2013-12-24 | 2015-05-20 | 福建省福抗药业股份有限公司 | 一种金霉素硫酸氢盐的生产方法 |
CN103833591B (zh) * | 2014-02-20 | 2015-07-15 | 宁夏泰瑞制药股份有限公司 | 一种盐酸金霉素的制备方法 |
CN104163774B (zh) * | 2014-07-30 | 2016-08-31 | 驻马店华中正大有限公司 | 一种提高金霉素钙盐产量的方法 |
CN104830939B (zh) * | 2015-06-02 | 2017-11-17 | 金河生物科技股份有限公司 | 金霉素发酵培养基灭菌及应用方法 |
CN105001112B (zh) * | 2015-06-30 | 2017-02-01 | 浦城正大生化有限公司 | 水溶性金霉素琥珀酸单酯盐及其制备方法 |
CN105001126B (zh) * | 2015-06-30 | 2018-03-06 | 浦城正大生化有限公司 | 金霉素甲磺酸盐及其生产方法 |
CN105067743B (zh) * | 2015-07-30 | 2016-09-14 | 金河生物科技股份有限公司 | 一种气相色谱法测定盐酸金霉素中氯乙烷方法 |
CN105861610A (zh) * | 2016-06-14 | 2016-08-17 | 成都中牧生物药业有限公司 | 基于提高四环素纯度的提纯方法 |
CN106399443A (zh) * | 2016-06-14 | 2017-02-15 | 成都中牧生物药业有限公司 | 一种四环素的提纯工艺 |
CN113549579B (zh) * | 2021-08-02 | 2022-08-16 | 金河生物科技股份有限公司 | 一种金霉素产量高、杂质比例低的金色链霉菌突变菌株及其应用 |
CN114276268B (zh) * | 2021-08-09 | 2023-11-07 | 浦城正大生化有限公司 | 一种超高水溶性和高生物利用度盐酸金霉素 |
CN114276267B (zh) * | 2021-08-09 | 2023-11-07 | 浦城正大生化有限公司 | 超高水溶性盐酸金霉素的制备方法 |
CN114105804B (zh) * | 2021-12-15 | 2023-09-15 | 浦城正大生化有限公司 | 一种盐酸金霉素的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2992274A (en) * | 1959-05-04 | 1961-07-11 | American Cyanamid Co | Process of preparing purified chlortetracycline hydrochloride |
CN101863797B (zh) * | 2010-07-07 | 2013-04-24 | 福建省福抗药业股份有限公司 | 一种制备盐酸金霉素的工艺 |
-
2012
- 2012-10-31 CN CN201210426529.0A patent/CN102898326B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102898326A (zh) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102898326B (zh) | 盐酸金霉素的制备方法 | |
CN105294467A (zh) | 一种从发酵液中提取饲料级缬氨酸的新工艺 | |
CN106478762B (zh) | 一种甘草酸二铵盐的制备方法 | |
CN103804172B (zh) | 一种提高有机酸产品质量的方法 | |
CN108191688A (zh) | 一种合成及结晶d-泛酸钙的方法 | |
CN102924311B (zh) | 一种l-天门冬氨酸-l-鸟氨酸盐的制备方法 | |
CN106631852A (zh) | 一种从l‑鸟氨酸发酵液中提取l‑鸟氨酸盐酸盐的方法 | |
CN102020593B (zh) | 从发酵液中直接结晶制备L-精氨酸-α-酮戊二酸盐的工艺 | |
CN103087017B (zh) | 炎琥宁粗品精制方法 | |
CN106748847A (zh) | 一种l‑丙氨酸的提取方法 | |
CN102391189A (zh) | 周效磺胺的制备方法 | |
WO2021212535A1 (zh) | 一种盐酸苯海索精制方法 | |
CN103483301A (zh) | 一种曲酸发酵液的分离纯化工艺 | |
CN103113440A (zh) | 一种硫氰酸红霉素的制备方法 | |
CN104894203A (zh) | 一种高纯度土霉素的生产工艺 | |
CN104610385A (zh) | 一种氨基葡萄糖盐酸盐的精制方法 | |
CN109265413A (zh) | 一种盐酸地芬尼多的制备方法及精制方法 | |
CN104529751B (zh) | 一种结晶l‑乳酸钙的制备方法 | |
CN104892554B (zh) | 一种赤霉酸ga3的制备方法 | |
CN106397409B (zh) | 一种坎地沙坦酯晶型i球形结晶的制备方法 | |
CN111518119B (zh) | 一种阿莫西林连续结晶工艺 | |
CN103421043A (zh) | 一种烷基酯法合成草甘膦水解工艺的改进方法 | |
CN106966916A (zh) | 一种土霉素降低拖尾峰含量的方法 | |
CN104447958B (zh) | 自发酵液中提取恩拉霉素的方法 | |
CN102731340A (zh) | 去甲基金霉素盐酸盐制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of Chlortetracycline Hydrochloride Effective date of registration: 20201228 Granted publication date: 20140319 Pledgee: INNER MONGOLIA BRANCH OF BANK OF COMMUNICATIONS Co.,Ltd. Pledgor: JINHE BIO-TECHNOLOGY Co.,Ltd. Registration number: Y2020150000082 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20140319 Pledgee: INNER MONGOLIA BRANCH OF BANK OF COMMUNICATIONS CO.,LTD. Pledgor: JINHE BIO-TECHNOLOGY Co.,Ltd. Registration number: Y2020150000082 |